翼状胬肉发病机制的研究进展

江华维; 刘霞; 王艳; 章敏慧; 尹维丹; 张利伟

doi:10.12259/j.issn.2095-610X.S20230125

翼状胬肉发病机制的研究进展

doi: 10.12259/j.issn.2095-610X.S20230125

云南大学附属医院/云南省第二人民医院/云南省眼科医院/昆明医科大学第四附属医院眼科，云南昆明　650021

基金项目: 国家自然科学基金资助项目（81860171）；云南省卫生健康委员会医学后备人才培养计划基金资助项目（H-2018020）；昆明医科大学研究生创新基金资助项目（2022S116）

详细信息

作者简介:
江华维（1994～），男，河南信阳人，在读硕士研究生，主要从事眼表疾病及小儿眼底病研究工作

通讯作者:
张利伟，E-mail：drzhangliwei@163.com

中图分类号: R777.33
计量
- 文章访问数: 3474
- HTML全文浏览量: 2066
- PDF下载量: 32
- 被引次数: 0
出版历程
- 收稿日期: 2022-11-19
- 网络出版日期: 2022-12-24
- 刊出日期: 2023-01-18

Research Progress on the Pathogenesis of Pterygium

Dept. of Ophthalmology，The Affiliated Hospital of Yunnan University，The 2nd People’s Hospital of Yunnan，Yunnan Eye Hospital，The 4th Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650021，China

摘要

摘要: 翼状胬肉是人群中常见的一种眼表疾病，其危险因素主要是紫外线照射，发病机制主要有氧化应激、光毒性、细胞增殖凋亡、细胞外基质重塑、炎症与免疫调控等。已发现了参与上述机制的多种重要蛋白，但它们在翼状胬肉中的调控信号通路尚不清楚，目前认为是多种机制共同作用的结果，其较完整的发病机制还有待进一步探索。就翼状胬肉的不同发病机制进行综述，以期待更好地了解翼状胬肉的发生发展，寻求新的治疗靶点和治疗方法，从而改善手术效果并减少术后复发。
- 翼状胬肉 /
- 发病机制 /
- 增殖与凋亡 /
- 炎症
Abstract: Pterygium is a common ocular surface disease in the population and its risk factors are mainly ultraviolet radiation. The pathogenesis mainly includes oxidative stress, phototoxicity, cell proliferation and apoptosis, extracellular matrix remodeling, inflammation and immune regulation. A variety of important proteins involved in the above mechanisms have been identified, but their regulatory signaling pathways in pterygium are still unclear and are currently considered to be the result of a combination of mechanisms, and their relatively complete pathogenesis needs further exploration. This paper aims to review the different pathogenesis of pterygium in order to better understand the occurrence and development of pterygium and seek new therapeutic targets and methods, so as to improve the surgical effect and reduce postoperative recurrence.
- Pterygium /
- Pathogenesis /
- Proliferation and apoptosis /
- Inflammation

HTML全文

参考文献(48)

[1]	Bradley J C,Yang W,Bradley R H,et al. The science of pterygia[J]. Br J Ophthalmol,2010,94(7):815-820. doi: 10.1136/bjo.2008.151852
[2]	Alqahtani J M. The prevalence of pterygium in Alkhobar: A hospital-based study[J]. J Family Community Med,2013,20(3):159-161. doi: 10.4103/2230-8229.121980
[3]	Rezvan F,Khabazkhoob M,Hooshmand E,et al. Prevalence and risk factors of pterygium: A systematic review and meta-analysis[J]. Surv Ophthalmol,2018,63(5):719-735. doi: 10.1016/j.survophthal.2018.03.001
[4]	Modenese A,Gobba F. Occupational exposure to solar radiation at different latitudes and pterygium: A systematic review of the last 10 years of scientific literature[J]. Int J Environ Res Public Health,2017,15(1):37. doi: 10.3390/ijerph15010037
[5]	Chalkia A K,Bontzos G,Spandidos D A,et al. Human papillomavirus infection and ocular surface disease (Review)[J]. Int J Oncol,2019,54(5):1503-1510.
[6]	Chalkia A K,Spandidos D A,Detorakis E T. Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review)[J]. Int J Mol Med,2013,32(3):539-543. doi: 10.3892/ijmm.2013.1438
[7]	Kalogeropoulos D,Papoudou-Bai A,Lane M,et al. Antigen-presenting cells in ocular surface diseases[J]. Int Ophthalmol,2020,40(6):1603-1618. doi: 10.1007/s10792-020-01329-0
[8]	Lin Y H,Sun C C,Yeung L,et al. Epidemiologic study of pterygium in Taiwan[J]. Jpn J Ophthalmol,2019,63(4):297-303. doi: 10.1007/s10384-019-00670-x
[9]	Khanna R C,Marmamula S,Cicinelli M V,et al. Fifteen-year incidence rate and risk factors of pterygium in the southern Indian state of Andhra Pradesh[J]. Br J Ophthalmol,2021,105(5):619-624. doi: 10.1136/bjophthalmol-2020-316359
[10]	Kilic-Toprak E,Toprak I,Caliskan S,et al. Oxidative stress and genotoxicity in pterygium: A systemic investigation[J]. Eye Contact Lens,2019,45(6):399-404. doi: 10.1097/ICL.0000000000000620
[11]	Graille M,Wild P,Sauvain J J,et al. Urinary 8-OHdG as a biomarker for oxidative stress: A systematic literature review and meta-analysis[J]. Int J Mol Sci,2020,21(11):3743. doi: 10.3390/ijms21113743
[12]	Josifovska N,Szabó D J,Nagymihály R,et al. Cultivation and characterization of pterygium as an ex vivo study model for disease and therapy[J]. Cont Lens Anterior Eye,2017,40(5):283-292. doi: 10.1016/j.clae.2017.04.002
[13]	Elgouhary S M,Elmazar H F,Naguib M I,et al. Role of oxidative stress and vascular endothelial growth factor expression in pterygium pathogenesis and prevention of pterygium recurrence after surgical excision[J]. Int Ophthalmol,2020,40(10):2593-2606. doi: 10.1007/s10792-020-01440-2
[14]	Gonzalez G,Sasamoto Y,Ksander B R,et al. Limbal stem cells: Identity,developmental origin,and therapeutic potential[J]. Wiley Interdiscip Rev Dev Biol,2018,7(2):e303.
[15]	Notara M,Lentzsch A,Coroneo M,et al. The role of limbal epithelial stem cells in regulating corneal (Lymph)angiogenic privilege and the micromilieu of the limbal niche following UV exposure[J]. Stem Cells Int,2018,2018(5):8620172.
[16]	Endl E,Hollmann C,Gerdes J. Antibodies against the Ki-67 protein: Assessment of the growth fraction and tools for cell cycle analysis[J]. Methods Cell Biol,2001,63(1):399-418.
[17]	Mahesh M,Mittal S K,Kishore S,et al. Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium[J]. Indian J Ophthalmol,2021,69(4):847-850. doi: 10.4103/ijo.IJO_1034_20
[18]	李娟,李宁,王剑锋,等. Bcl-2、Bax、Ki67在原发性翼状胬肉组织中的表达研究[J]. 国际眼科杂志,2018,18(5):960-962. doi: 10.3980/j.issn.1672-5123.2018.5.49
[19]	Tagami M,Kakehashi A,Sakai A,et al. Expression of thrombospondin-1 in conjunctival squamous cell carcinoma is correlated to the Ki67 index and associated with progression-free survival[J]. Graefes Arch Clin Exp Ophthalmol,2021,259(10):3127-3136. doi: 10.1007/s00417-021-05236-7
[20]	Ohara M,Sotozono C,Tsuchihashi Y,et al. Ki-67 labeling index as a marker of malignancy in ocular surface neoplasms[J]. Jpn J Ophthalmol,2004,48(6):524-529. doi: 10.1007/s10384-004-0129-0
[21]	Suarez M F,Echenique J,López J M,et al. Transcriptome analysis of pterygium and pinguecula reveals evidence of genomic instability associated with chronic inflammation[J]. Int J Mol Sci,2021,22(21):12090. doi: 10.3390/ijms222112090
[22]	González-Magaña A,Blanco F J. Human PCNA structure,function and interactions[J]. Biomolecules,2020,10(4):570. doi: 10.3390/biom10040570
[23]	Wang Y L,Wu W R,Lin P L,et al. The functions of PCNA in tumor stemness and invasion[J]. Int J Mol Sci,2022,23(10):5679. doi: 10.3390/ijms23105679
[24]	Das P,Gokani A,Bagchi K,et al. Limbal epithelial stem-microenvironmental alteration leads to pterygium development[J]. Mol Cell Biochem,2015,402(1-2):123-139. doi: 10.1007/s11010-014-2320-z
[25]	Liang K,Jiang Z,Ding B Q,et al. Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva[J]. Mol Vis,2011,17(8):1687-1693.
[26]	Tchakarska G,Sola B. The double dealing of cyclin D1[J]. Cell Cycle,2020,19(2):163-178. doi: 10.1080/15384101.2019.1706903
[27]	Nubile M,Curcio C,Lanzini M,et al. Expression of CREB in primary pterygium and correlation with cyclin D1,ki-67,MMP7,p53,p63,survivin and vimentin[J]. Ophthalmic Res,2013,50(2):99-107. doi: 10.1159/000347124
[28]	Ljubojević V,Gajanin R,Amidzić L,et al. The expression and significance of p53 protein and Ki-67 protein in pterygium[J]. Vojnosanit Pregl,2016,73(1):16-20. doi: 10.2298/VSP140428124L
[29]	Wheatley S P,Altieri D C. Survivin at a glance[J]. J Cell Sci,2019,132(7):jcs223826. doi: 10.1242/jcs.223826
[30]	Zhang L W,Chen B H,Xi X H,et al. Survivin and p53 expression in primary and recurrent pterygium in Chinese patients[J]. Int J Ophthalmol,2011,4(4):388-392.
[31]	Süren E,Nergiz D,Bilgin B,et al. The role of cyclin D1,BCL-2,p53 and Ki-67 in epithelial cells in the etiopathogenesis of pterygium[J]. Indian J Pathol Microbiol,2021,64(2):238-242.
[32]	Shen J,Li H,Chen Y,et al. MiR-15a participated in the pathogenesis of pterygium via targeting BCL-2: An experimental research[J]. Curr Eye Res,2022,47(1):32-40. doi: 10.1080/02713683.2021.1952603
[33]	Dong S,Wu X,Xu Y,et al. Immunohistochemical study of STAT3,HIF-1α and VEGF in pterygium and normal conjunctiva: Experimental research and literature review[J]. Mol Vis,2020,26(7):510-516.
[34]	Martín-López J,Pérez-Rico C,García-Honduvilla N,et al. Elevated blood/lymphatic vessel ratio in pterygium and its relationship with vascular endothelial growth factor (VEGF) distribution[J]. Histol Histopathol,2019,34(8):917-929.
[35]	Malozhen S A,Trufanov S V,Krakhmaleva D A. Antiangiogenic therapy in the surgical treatment of pterygium[J]. Vestn Oftalmol,2020,136(5.Vyp.2):177-183.
[36]	Syed V. TGF-β signaling in cancer[J]. J Cell Biochem,2016,117(6):1279-1287. doi: 10.1002/jcb.25496
[37]	Fan J,Zhang X,Jiang Y,et al. SPARC knockdown attenuated TGF-β1-induced fibrotic effects through Smad2/3 pathways in human pterygium fibroblasts[J]. Arch Biochem Biophys,2021,713(11):109049.
[38]	Bianchi E,Scarinci F,Grande C,et al. Immunohistochemical profile of VEGF,TGF-β and PGE₂ in human pterygium and normal conjunctiva: Experimental study and review of the literature[J]. Int J Immunopathol Pharmacol,2012,25(3):607-615. doi: 10.1177/039463201202500307
[39]	Awdeh R M,DeStafeno J J,Blackmon D M,et al. The presence of T-lymphocyte subpopulations (CD4 and CD8) in pterygia: Evaluation of the inflammatory response[J]. Adv Ther,2008,25(5):479-487. doi: 10.1007/s12325-008-0056-4
[40]	Turan M,Turan G. Overexpression of fractalkine and its histopathological characteristics in primary pterygium[J]. Graefes Arch Clin Exp Ophthalmol,2019,257(12):2743-2750. doi: 10.1007/s00417-019-04463-3
[41]	Belviranli S,Oltulu R,Gundogan A O,et al. Evaluation of the systemic inflammation in patients with pterygium: Monocyte-to- high-density lipoprotein cholesterol ratio and hematologic indexes of inflammation[J]. Middle East Afr J Ophthalmol,2021,28(4):211-215. doi: 10.4103/meajo.meajo_75_21
[42]	Abubakar S A,Isa M M,Omar N,et al. Relative quantification of human β-defensins gene expression in pterygium and normal conjunctiva samples[J]. Mol Med Rep,2020,22(6):4931-4937. doi: 10.3892/mmr.2020.11560
[43]	Tiong K I,Mohd Zahidin A Z,Sumugam S K A,et al. Evaluation of interleukin-17 and interleukin-23 in pterygium: Immunohistochemistry study[J]. Asia Pac J Ophthalmol (Phila),2017,6(5):403-406.
[44]	Zidi S,Bediar-Boulaneb F,Belguendouz H,et al. Local pro-inflammatory cytokine and nitric oxide responses are elevated in patients with pterygium[J]. Int J Immunopathol Pharmacol,2017,30(4):395-405. doi: 10.1177/0394632017742505
[45]	Yoo T K,Kim S W,Seo K Y. Association between serum immnunoglobulin E and pterygium: A population-based study from south Korea[J]. Curr Eye Res,2018,43(9):1090-1096. doi: 10.1080/02713683.2018.1484145
[46]	Cui N,Hu M,Khalil R A. Biochemical and biological attributes of matrix metalloproteinases[J]. Prog Mol Biol Transl Sci,2017,147(3):1-73.
[47]	Tsai Y Y,Chiang C C,Yeh K T,et al. Effect of TIMP-1 and MMP in pterygium invasion[J]. Invest Ophthalmol Vis Sci,2010,51(7):3462-3467. doi: 10.1167/iovs.09-4921
[48]	Cui Y H,Feng Q Y,Liu Q,et al. Posttranscriptional regulation of MMP-9 by HuR contributes to IL-1β-induced pterygium fibroblast migration and invasion[J]. J Cell Physiol,2020,235(6):5130-5140. doi: 10.1002/jcp.29387

计量

文章访问数: 3474
HTML全文浏览量: 2066
PDF下载量: 32
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

翼状胬肉发病机制的研究进展

doi: 10.12259/j.issn.2095-610X.S20230125

作者简介:
江华维（1994～），男，河南信阳人，在读硕士研究生，主要从事眼表疾病及小儿眼底病研究工作

通讯作者:
张利伟，E-mail：drzhangliwei@163.com

计量

Research Progress on the Pathogenesis of Pterygium

计量

目录

[1]	聂绍燕, 范苏苏, 朱钰珊, 彭学容, 王洋, 张旋. 喜炎平注射液对脂多糖诱导的急性肺损伤小鼠的保护作用研究, 昆明医科大学学报.
[2]	贾政, 邢正江, 刘茜, 杜义斌, 李冰, 解英, 赵义. 建立大鼠心肌缺血与体外CMECs缺氧模型-观察对冠脉微循环的影响, 昆明医科大学学报.
[3]	李妍平, 董小林, 李青芸, 李红梅, 魏欢, 曾毅. miR-21-5p通过抑制STAT3缓解OGD诱导的HT22细胞炎症和凋亡并促进增殖, 昆明医科大学学报.
[4]	杨顺航, 李炯明, 刘建和, 王光, 李沛. 肠源性高草酸尿症的发病机制与治疗进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220734
[5]	武翠玲, 刘弘毅, 范源, 刘嘉瑞. 糖尿病脑病的发病机制研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220733
[6]	徐凡, 郭方圆, 何燕, 魏向群. 子宫腺肌病患者外周血血细胞及凝血功能的临床分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211124
[7]	杨丽晗, 张志毕, 杨晖, 杨江兰, 虎丹, 杨晓丽, 罗朝昱, 张媛, 张荣平. 两种血竭凝胶抗炎抗菌效果比较, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210134
[8]	杨绍艳, 伍路, 张素仙. miRNAs在子宫内膜异位症发生发展中的作用研究进展, 昆明医科大学学报.
[9]	黄治国, 殷维, 晏毅. 瑞芬太尼抑制大鼠炎症性疼痛及其机制, 昆明医科大学学报.
[10]	刘华, 岳万远, 骆琦, 邵帅, 张亮, 代晓明. TATA结合蛋白在舌粘膜癌变中的过表达, 昆明医科大学学报.
[11]	梁昕悦, 郭皓. 线粒体解偶联蛋白2与高血压的研究进展, 昆明医科大学学报.
[12]	李東霖, 吴文娟, 邹丹丹, 何黎. 痤疮研究进展, 昆明医科大学学报.
[13]	杨再英. 骨质疏松症对骨性关节炎发病机制的影响, 昆明医科大学学报.
[14]	张福厚. 半乳糖凝集素与静脉血栓形成机制的研究进展, 昆明医科大学学报.
[15]	张洋. 炎症及氧化应激反应在慢性阻塞性肺疾病发病机制中的研究进展, 昆明医科大学学报.
[16]	李艳. 天麻成分对羟基苯甲醇抗实验性脑血栓形成及抗炎作用研究, 昆明医科大学学报.
[17]	苏莹. 慢性乙型肝炎患者外周血Th17细胞的变化及意义, 昆明医科大学学报.
[18]	杨文举. 角膜缘干细胞移植术治疗翼状胬肉临床疗效观察, 昆明医科大学学报.
[19]	夏英杰. SD大鼠髁状突颈部骨折对大鼠髁状突软骨细胞增殖与凋亡的影响, 昆明医科大学学报.
[20]	李玉晓. 克拉霉素治疗FESS后鼻窦黏膜迁延性炎症的临床研究, 昆明医科大学学报.

留言板

翼状胬肉发病机制的研究进展

doi: 10.12259/j.issn.2095-610X.S20230125

作者简介: 江华维（1994～），男，河南信阳人，在读硕士研究生，主要从事眼表疾病及小儿眼底病研究工作

通讯作者: 张利伟，E-mail：drzhangliwei@163.com

计量

出版历程

Research Progress on the Pathogenesis of Pterygium

计量

出版历程

目录

作者简介:
江华维（1994～），男，河南信阳人，在读硕士研究生，主要从事眼表疾病及小儿眼底病研究工作

通讯作者:
张利伟，E-mail：drzhangliwei@163.com